Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

SYSPATHO · New Algorithms for Host Pathogen Systems Biology

FP7Status: CLOSED1 October 201031 March 2015EU funding €2,942,425

SYSPATHO focuses on the development of novel and generally applicable mathematical methods and algorithms for systems biology. These methods and algorithms will be applied to study the complex interactions of hepatitis C virus (HCV), a human-pathogenic virus of high medical relevance, with its host at the systems level. Using a multidisciplinary, integrative approach, PATHOSYS will (a) develop methods to analyze and integrate a wide variety of data from wet lab experiments, databases and biological literature, (b) develop and apply machine learning tools to reconstruct and study intracellular interaction networks from experimental data, (c) develop new and improve existing algorithms and mathematical methods for bottom-up modelling, to fit models to data, and to analyze the dynamic behaviour of models (d) generate new experimental data to gain novel insights into hepatitis C virus host interactions, and (e) use the newly developed methods and data to model and analyze HCV-host interactions at the systems level. Guided by biological data, PATHOSYS focuses on the design of novel algorithms and mathematical methods for systems biology, with the aim to provide generally applicable tools to elucidate biological processes. Based on developed models and using systems analysis, PATHOSYS will elucidate virus host interactions of Hepatitis C virus at an unprecedented level. As a direct spin-off, models and analysis methods developed in PATHOSYS will lead to the identification of new candidate host cell target genes applicable for the design of novel anti-viral drugs against hepatitis C. Targeting of host cell factors will reduce the likelihood for the development of therapy resistance and increase the chance for broad-spectrum antivirals. Inclusion of two SME partners will ensure exploitation of results generated in PATHOSYS and their transfer into industrial and pharmaceutical applications, thus strengthening economy and health care system in Europe.

Consortium · 11 organisations

coordinator

RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG

DE · €729,379

participant

NOVAMECHANICS LIMITED

CY · €307,200

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €513,600

participant

PETER THE GREAT SAINT PETERSBURG POLYTECHNIC UNIVERSITY

RU · €181,440

participant

SOFTWARE SYSTEMS-PREDICTING BIOLOGY OOO

RU · €211,405

participant

BRAUDE COLLEGE OF ENGINEERING KARMIEL R A

IL · €37,872

participant

UNIVERSITATSKLINIKUM HEIDELBERG

DE · €449,552

participant

The Establishment of the Russian Academy of Sciences Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences

RU · €134,132

participant

MIDDLE EAST TECHNICAL UNIVERSITY

TR · €59,825

participant

TECHNISCHE UNIVERSITAET DRESDEN

DE · €283,620

participant

BAHCESEHIR UNIVERSITESI

TR · €34,400

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.